Live Breaking News & Updates on Disc Medicine Daily

Stay updated with breaking news from Disc medicine daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Disc Medicine (NASDAQ:IRON) Earns Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research report released on Tuesday morning, Benzinga reports. The firm currently has a $85.00 price objective on the stock. Several other equities research analysts also recently commented on the company. Morgan Stanley reduced their target price on Disc […] ....

United States , Raymond James , Stifel Nicolaus , William Richard White , Charles Schwab Investment Management Inc , Morgan Stanley , Disc Medicine Company Profile , York Mellon Corp , Barclays Plc , Disc Medicine Inc , Cantor Fitzgerald , Swiss National Bank , Victory Capital Management Inc , Disc Medicine , Free Report , Moderate Buy , Medicine Stock Down , Get Free Report , Director William Richard White , New York Mellon Corp , Capital Management , National Bank , Charles Schwab Investment Management , Schwab Investment Management , Disc Medicine Daily ,

Disc Medicine's (IRON) "Overweight" Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $85.00 target price on the stock. IRON has been the subject of a number of other reports. Wedbush reaffirmed an outperform rating and set a $43.00 price […] ....

United States , Raymond James , William Richard White , Stifel Nicolaus , Jennison Associates , Disc Medicine Company Profile , Victory Capital Management Inc , Cantor Fitzgerald , Pricet Rowe Associates Inc , Disc Medicine Inc , First Turn Management , Disc Medicine , Free Report , Moderate Buy , Get Free Report , Director William Richard White , Turn Management , Capital Partners , Victory Capital Management , Disc Medicine Daily ,

Disc Medicine (NASDAQ:IRON) Stock Rating Reaffirmed by Cantor Fitzgerald

Disc Medicine (NASDAQ:IRON – Get Free Report)‘s stock had its “overweight” rating restated by stock analysts at Cantor Fitzgerald in a research report issued on Tuesday, Benzinga reports. They currently have a $85.00 price target on the stock. Cantor Fitzgerald’s target price would indicate a potential upside of 148.97% from the company’s current price. Several […] ....

United States , Raymond James , William Richard White , Disc Medicine Inc , Morgan Stanley , Bleakley Financial Group , China Universal Asset Management Co , Proshare Advisors , Cantor Fitzgerald , Securities Exchange Commission , Disc Medicine , Get Free Report , Director William Richard White , Exchange Commission , Universal Asset Management , Share Advisors , Disc Medicine Daily ,

Disc Medicine's (IRON) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research note released on Tuesday morning, Benzinga reports. They currently have a $85.00 price target on the stock. Several other research analysts have also weighed in on IRON. Stifel Nicolaus upped their price target on Disc Medicine from […] ....

United States , Stifel Nicolaus , Raymond James , William Richard White , Securities Exchange Commission , Charles Schwab Investment Management Inc , Victory Capital Management Inc , Disc Medicine Inc , Swiss National Bank , Barclays Plc , York Mellon Corp , Cantor Fitzgerald , Disc Medicine , Free Report , Moderate Buy , Get Free Report , Director William Richard White , Exchange Commission , New York Mellon Corp , Capital Management , National Bank , Charles Schwab Investment Management , Schwab Investment Management , Disc Medicine Daily ,

Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Recommendation of "Moderate Buy" from Analysts

Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven brokerages that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month target price […] ....

United States , William Richard White , Raymond James , Stifel Nicolaus , Morgan Stanley , Disc Medicine Inc , Profund Advisors , Vanguard Group Inc , Charles Schwab Investment Management Inc , Disc Medicine , Get Free Report , Director William Richard White , Capital Partners , Schwab Investment Management , Hudson Bay Capital Management , Get Free , Disc Medicine Daily ,